SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (9899)10/21/1997 11:35:00 AM
From: chirodoc  Respond to of 32384
 
<<<<<<Speaking of LLY, its new SERM, Evista (Raloxifene) was the June "molecule of the month"

.....if you want a piggy back ride.......choose a big boy to carry you

......ligand imho picked the best and brightest big pharma.....i think it's a smart move

......lilly is up today and evista, from what i have heard is so good that it has helped to contribute to a sell-off in merck.......people think that merck's pipeline is poorer than lilly, especially now that they have agreement with ligand!!!! :->



To: Henry Niman who wrote (9899)10/21/1997 11:35:00 AM
From: CYBERKEN  Respond to of 32384
 
LGND vol looks heavy. Wonder why the warrant hasn't traded yet.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News